Mesalamine Suspension
Product Images NDC 72162-2302

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 72162-2302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

An instructional illustration showing a hand grasping a sealed pouch at the seam with scissors cutting it open. The diagram labels the 'Grasp seam and tear down' area of the pouch, indicating how to open the packaging.*

FDA Label Image

Image-02 (Image 02)

An instructional illustration showing two hands holding a rectal applicator syringe for administering Mesalamine suspension. The left hand grips the applicator cylinder, and the right hand holds the removable tip or nozzle, demonstrating how to separate the parts before use.*

FDA Label Image

Image-03 (Image 03)

An anatomical illustration showing a person lying on their left side with the right leg bent forward and the left arm positioned behind the back. The image likely demonstrates the recommended posture for rectal administration of medication.*

FDA Label Image

Image-04 (Image 04)

An illustration depicts a person positioned on their knees and forearms with their hips raised, head lowered between the arms, and back curved downward. This diagram likely shows a recommended posture or position related to the rectal administration of medication.*

FDA Label Image

Image-05 (Image 05)

An illustration showing a hand holding and squeezing a tube, which appears to dispense a substance. The image suggests a usage or administration method typically associated with a topical or rectal medication. No labels or text are visible in this drawing.*

FDA Label Image

Extended Label (Lbl721622302.1)

This text panel provides directions for dosage and handling of Mesalamine suspension 4 g/60 mL rectal product. It advises that one unit-dose suspension should be taken in the evening before bed, dispensed in existing foil-wrapped packaging without repackaging, and that individual trays are not to be dispensed separately. It also notes the product contents may darken over time.*

FDA Label Image

Label (Lbl721622302)

Label for Mesalamine Rectal Suspension USP Enema Kit containing 4 g/60 mL suspension. The label indicates it is packaged as 7 unit-dose bottles of 60 mL each. It is relabeled by Bryant Ranch Prepack, with a barcode and NDC 72162-2302-2. Storage instructions and usage cautions are also visible.*

FDA Label Image

Str (Str)

Chemical structure of Mesalamine showing a benzene ring with amino, hydroxyl, and carboxyl functional groups attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.